Screening Questionnaires and Musculoskeletal Ultrasound for Early Detection of Spondyloarthritis in IBD Patients
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: DETAIL .IBIS_Q . MSUS.
- Who it may be relevant to
- Registry conditions: Inflamatory Bowel Disease, Spondylarthritis. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Egypt
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Incremental Value of Musculoskeletal Ultrasound After DETAIL and IBIS-Q Screening for Early Detection of IBD-associated Spondyloarthritis.
Overview
This study aims to evaluate the screening performance of the DETAIL and IBIS-Q questionnaires followed by musculoskeletal ultrasound (MSUS) for the early detection of spondyloarthritis in patients previously diagnosed with Inflammatory Bowel Disease (IBD).
Detailed description
Inflammatory bowel disease (IBD) is frequently associated with extraintestinal manifestations, with spondyloarthritis (SpA) being the most common. Early detection is crucial to prevent structural damage. This prospective study will screen consecutive adult patients with IBD using the DETAIL and IBIS-Q questionnaires. Patients will then undergo a comprehensive clinical and musculoskeletal ultrasound (MSUS) assessment to evaluate the incremental diagnostic value of ultrasound in detecting early and subclinical SpA.
Interventions
- Diagnostic test DETAIL .IBIS_Q . MSUS
All patients will be screened using the DETAIL and IBIS-Q questionnaires, followed by a comprehensive musculoskeletal ultrasound (MSUS) assessment.
Primary outcome measures
- Prevalence of undiagnosed spondyloarthritis [Time frame: At the time of clinical evaluation (up to 12 months)]
Eligibility criteria
Inclusion criteria
Adult Aged 18 years old or more Confirmed diagnosis of IBD (by established clinical, endoscopic, and histopathological criteria).
Patient provides informed written consent to participate
Exclusion criteria
Known, pre-existing diagnosis of Spondyloarthritis or any other concomitant systemic autoimmune rheumatic disease.
Severe secondary osteoarthritis or major joint trauma/surgery mimicking SpA. Cognitive impairment or communication barriers preventing comprehension or completion of questionnaires
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Egypt · 1 center
- Assiut University Hospital — Asyut
Identifiers
NCT: NCT07721844 · Assiut-IBD-MSUS